Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218062 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 73
- Enrollment target
NCT00218062: Completed Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
NCT00218062 is a Phase 2 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 73 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218062, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 73 participants
- Enrollment target
Study Summary
Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to examine the effects of d-amphetamine and modafinil, when given alone and in combination, in treating cocaine dependent individuals.
Interventions
- BEHAVIORAL Therapy
- DRUG D-Amphetamine 30mg
- DRUG D-Amphetamine 60mg
- DRUG Modafinil 200mg
- DRUG Modafinil 400mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2006-03 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
What the finished NCT00218062 record still lists
NCT00218062 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 5 interventions - of which Therapy is the first listed.
NCT00218062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218062 about?
NCT00218062 is a clinical study titled "Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals". Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to examine the effects of d-amphetamine and modafinil, when given alone and in combination, in treating cocaine dependent individual...
What is the current status of trial NCT00218062?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 73 participants. The study started on 2006-03. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00218062?
The interventions under investigation include: Therapy (BEHAVIORAL), D-Amphetamine 30mg (DRUG), D-Amphetamine 60mg (DRUG), Modafinil 200mg (DRUG), Modafinil 400mg (DRUG).
Who is sponsoring clinical trial NCT00218062?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00218062's enrollment target sits among peer trials
73 924th of 2000 higher than 1,076 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia